Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation

People with opioid use disorders are overrepresented in correctional facilities, and are at high risk of opioid overdose. Despite the fact that buprenorphine/naloxone is the first line treatment for people with opioid use disorder, there are often institutional, clinical, and logistical barriers to...

Descripción completa

Detalles Bibliográficos
Autores principales: Regenstreif, Lori, Sadik, Marina, Beaulieu, Erin, Bodkin, Claire, Kiefer, Lori, Guenter, Dale, Lee, Patsy W. P., Kouyoumdjian, Fiona G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889394/
https://www.ncbi.nlm.nih.gov/pubmed/35235073
http://dx.doi.org/10.1186/s40352-022-00174-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889394/
https://www.ncbi.nlm.nih.gov/pubmed/35235073
http://dx.doi.org/10.1186/s40352-022-00174-w

Ejemplares similares